GlassScriptPhysician profile
Regina Phillips
NPI 1740218890
$726.08
in general payments reported to CMS, 2019-2025
14 companies · $55.07 in 2025
The $55.07 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $151 · 2021: $20.79 · 2022: $44.09 · 2023: $35.82 · 2024: $202 · 2025: $55.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $140.55 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $114.31 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $109.27 | 2020-2023 | Vibativ |
| Boston Scientific Corporation | $102.53 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Melinta Therapeutics, LLC | $56.30 | 2019 | |
| Paratek Pharmaceuticals, INC. | $55.21 | 2019-2024 | Nuzyra |
| Cardiovascular Systems INC. | $30.96 | 2020 | |
| Mckesson Patient Care Solutions INC. | $20.56 | 2019 | |
| Integra Lifesciences Corporation | $20.27 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $17.66 | 2019 | |
| Surgenex LLC | $16.99 | 2025 | Renograft, Ardeograft, Surgraft |
| Misonix INC | $14.30 | 2020 | |
| Convatec INC. | $13.63 | 2020 | |
| Allergan, INC. | $13.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.